ライフサイエンスコーパス: femoral

1 Carotid, aortic, and ilio-femoral (18)F-FDG PET/MRI was performed in 755 individua

2 n was present in 48.2% of individuals (24.4% femorals, 19.3% aorta, 15.8% carotids, and 9.3% iliacs)

3 Carotid and femoral 3-dimensional vascular ultrasound and cardiac co

4 and 9.3% iliacs) and plaques in 90.1% (73.9% femorals, 55.8% iliacs, and 53.1% carotids).

5 v) was significantly higher with radial than femoral access (41 muSv; p = 0.02).

6 ar whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney

7 emaining D2B time and the odds of undergoing femoral access (P=0.73).

8 imilar when analyzing radial-only versus any femoral access and when excluding the largest study.

9 nd 90 minutes or an increased preference for femoral access correlated with decreasing time to meet t

10 yndrome, were randomly assigned to radial or femoral access for coronary angiography and percutaneous

11 at prohibitively high risk or render common femoral access impossible.

12 ber 2018 reporting the outcomes of RA versus femoral access in CTO percutaneous coronary intervention

13 operators were increasingly likely to pursue femoral access in patients with less time to meet the 90

14 omized controlled trial comparing radial and femoral access in women undergoing cardiac catheterizati

15 In 2019, for the entire cohort, femoral access increased to 95.3%, hospital stay was 2 d

16 Femoral access is the gold standard for transcatheter ao

17 oral TAVR and may be a safe alternative when femoral access risk is considered too high.

18 atients (P for trend = .22) and in the large femoral access subgroup (P trend = .47).

19 1%]; and 85 147 patients [83.9%] treated via femoral access), 30-day postprocedure follow-up data was

20 (single or bifemoral or combined radial and femoral access).

21 Seventy-three (28%) patients had femoral access, and 189 (72%) had IJ access; demographic

22 Conclusions As compared with femoral access, RA is used in CTO percutaneous coronary

23 ation, most cases are elective, performed by femoral access, with interruption of OAC.

24 they have not been accurately compared with femoral access.

25 , 0.12-1.07; P=0.07; I(2)=0%) as compared to femoral access.

26 es in patients undergoing RA using radial or femoral access.

27 and DAP were higher with radial compared to femoral access: 10 min versus 9 min (p < 0.0001) and 65

28 ls in the subcutaneous abdominal and gluteal/femoral adipose tissue (SAT) of weight-stable obese adol

29 eration as tissue engineered periosteum in a femoral allograft mouse model similar to fresh passaged

30 We found adult femoral alpha-catulin-GFP+ or Mds1GFP/+Flt3Cre HSCs prox

31 through the hip-knee-ankle angle (HKAA) and femoral anatomic-mechanical angle (AMA).

32 s (76.9%), and six patients (46.2%) had both femoral and jugular cannula-associated deep vein thrombo

33 nization was significantly different between femoral and nonfemoral sites.

34 uding 101 430 patients who were treated with femoral and nonfemoral TAVR at 521 US hospitals in the S

35 ular function and stiffness of the involved (femoral and popliteal) and uninvolved (brachial) arterie

36 rganisms was significantly different between femoral and radial site (p < 0.01).

37 To examine its role in bone we analyzed femoral and vertebral bone mass by micro-computed tomogr

38 ve participants with symptomatic superficial femoral and/or popliteal artery disease at 11 German cen

39 x systolic arterial pressure at the carotid, femoral, and radial artery level.

40 ose tissue mass, particularly in the gluteal-femoral area.

41 Through femoral arterial access, high fidelity pressure catheter

42 lization were assessed at peak exercise from femoral arterial and venous blood samples and leg blood

43 Femoral arterial calcification at baseline and 6 mo was

44 re anaesthetized and ABP was monitored via a femoral arterial catheter.

45 ral dP/dtmax, systolic, diastolic, and pulse femoral arterial pressure were obtained from the pressur

46 Following euthanasia, femoral arterial segments were isolated and endothelial

47 descending genicular artery (1), perforating femoral arteries (3), posterior tibial recurrent artery

48 DRG neurons isolated from rats with ligated femoral arteries (a model of PAD).

49 lculate the endovascular distances from both femoral arteries at the level of the upper border of the

50 methyl-l-arginine acetate (l-NMMA) into both femoral arteries reversed the insulin-stimulated increas

51 e, the hindlimb muscles of rats with ligated femoral arteries show increased levels of reactive oxyge

52 Injured femoral arteries showed a 20% increase in neointimal hyp

53 nd 97.9% of CT scans from the right and left femoral arteries, respectively.

54 on on the pressor reflex in rats with patent femoral arteries.

55 ygen species production in rats with ligated femoral arteries.

56 vivo on isolated aortas, but also in vivo on femoral arteries.

57 A hyperinsulinemic-euglycemic clamp with femoral arteriovenous balance and glucose tracer was app

58 perficial external pudendal artery (2), deep femoral artery (1), lateral circumflex femoral artery (3

59 umflex femoral artery (3), medial circumflex femoral artery (2), articular branch of descending genic

60 deep femoral artery (1), lateral circumflex femoral artery (3), medial circumflex femoral artery (2)

61 Angioplasty for the Treatment of Superficial Femoral Artery [SFA] and Proximal Popliteal Artery [PPA]

62 f Atherosclerotic Lesions in the Superficial Femoral Artery [SFA] and/or Proximal Popliteal Artery [P

63 Common femoral artery access is the default strategy for large-

64 rats whereby microspheres injected into the femoral artery allowed a unilateral reduction in functio

65 h rat underwent catheterization of the right femoral artery and left femoral vein.

66 The common femoral artery and vein were catheterized for drug infus

67 city and oxygenation (SvO(2)) in superficial femoral artery and vein, respectively, along with artery

68 f Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery [MDT-211

69 f Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using th

70 Eight 50 kg Yorkshire swine with a femoral artery catheter for blood pressure measurement a

71 s, such as middle cerebral artery occlusion, femoral artery clipping, and complete or incomplete cort

72 We use carotid ligation and femoral artery denudation models in mice with global or

73 on the endothelium of a biopsy specimen of a femoral artery from an APS patient.

74 Permanent ligation of the femoral artery in C57BL/6 J mice enlarged pre-existing c

75 sive failure to rebleeding in a rat model of femoral artery injury, and identified mechanisms that co

76 Femoral artery ligation and resection were used as an in

77 iments in preclinical PAD models (unilateral femoral artery ligation and resection) were conducted to

78 lost following genetic deletion of FOXC2 or femoral artery ligation to reduce venous flow in mice, a

79 METHODS AND Recovery of blood flow after femoral artery ligation was impaired (>80%) in AMPKalpha

80 In a mouse model of arteriogenesis (femoral artery ligation), we found that endothelial cell

81 plants and hind limb revascularization after femoral artery ligation.

82 n recovery and increased tissue injury after femoral artery ligation.

83 valuate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions With A Novel Paclita

84 We used right femoral artery or radial artery access to catheterize th

85 ue resistance (P < 0.001), despite preserved femoral artery perfusion.

86 Central (carotid-femoral artery PWV, PWV(CF) ) and peripheral (carotid-ra

87 al artery disease due to de novo superficial femoral artery stenotic or occlusive lesions were random

88 Femoral artery thrombosis was documented in 6 (9%) infan

89 Femoral artery wire injury was performed in SMC-conditio

90 tion of beta1 integrin attenuated FMD of the femoral artery, and blocking of beta1 integrin function

91 el and a neointimal hyperplasia model of the femoral artery.

92 paclitaxel-coated devices in the superficial femoral artery.

93 was identified in seven patients (53.8%), a femoral associated cannula-associated deep vein thrombos

94 ssociated with carotid and coronary, but not femoral atherosclerosis, and with cardiovascular mortali

95 -ZH-2017-01395) for presence of DFCIs at the femoral attachment of the medial head of the gastrocnemi

96 he decreased mobility indicated by decreased femoral bending strength.

97 flow) and constant infusion thermodilution (femoral blood flow) with net exchange calculated via the

98 MIV-711 significantly reduced medial femoral bone area progression (P = 0.002 for 100 mg/d an

99 In-vivo investigation of critical-size femoral bone defects repair revealed that CSi@CSi-Mg6 an

100 allenge, with a positive correlation between femoral bone marrow fungal infiltration at 48 h and prot

101 rtum exposure to 20 mg/kg fluoxetine reduced femoral bone mineral density and bone volume fraction, n

102 -overexpressing PC3 cells implanted into the femoral bone of male SCID mice caused massive bone loss

103 sue microarray (TMA) analysis to a sample of femoral bone specimens from 20 exhumed individuals of kn

104 asion, and tumor-induced skeletal lesions in femoral bone.

105 Femorofemoral cannulation induced femoral cannula-associated deep vein thrombosis more fre

106 These three patients had femoral cannula-associated deep vein thrombosis, and two

107 verall, (mean +/- SEM) patellar, tibial, and femoral cartilage T1rho relaxation times significantly d

108 Suprapatellar effusion and reduced lateral femoral cartilage thickness were more prevalent in the h

109 d, which included reduced lateral and medial femoral cartilage thickness, suprapatellar effusion, and

110 100 mg/d and 0.004 for 200 mg/d) and medial femoral cartilage thinning (P = 0.023 for 100 mg/d and 0

111 Compared with outpatient femoral cases, outpatient IJ cases had 62% (52%-69%) fas

112 atio [OR]: 2.7 [95% CI: 1.1, 6.6]; P = .02), femoral catheter access (OR: 2.5 [95% CI: 1.1, 5.6]; P =

113 seudomonal therapy should be considered if a femoral catheter-related bloodstream infection is suspec

114 agulation results (64.5% vs 44.4%; P = .03), femoral catheters (16.1% vs 5.5%; P = .02), repair and/o

115 agulation results (49.3% vs 35.7%; P = .02), femoral catheters (9.6% vs 3.9%; P = .03), repair and/or

116 etal sheep were catheterized with aortic and femoral catheters and a flow transducer around the exter

117 tion gradients across the human cerebral and femoral circulation at rest and during exercise, an idea

118 ction, a reduction in oxygen delivery to the femoral circulation, worsening fetal acidosis.

119 not associated with whether patients in the femoral cohort were (0.55%) or were not (0.52%) treated

120 not associated with whether patients in the femoral cohort were (0.57%) or were not (0.55) treated w

121 The tip of the medial femoral condyle (MFC), which contained HAC, ACC, and SCB

122 SL imaging of knee bone marrow in the distal femoral condyle at 3 T.

123 on imaging of knee bone marrow in the distal femoral condyle at a 3 T MRI scanner, a study was perfor

124 y to compare MSCs from medial and lateral OA femoral condyles.

125 features that pertain to bone quality in the femoral cortical and trabecular compartments of male and

126 Purpose To compare the prevalence of distal femoral cortical irregularities (DFCIs) at different ten

127 Conclusion A distal femoral cortical irregularity at the attachment sites of

128 CVC-related thrombosis during admission and femoral CVC placement was predictive of residual thrombo

129 ed to determine prevalence and predictors of femoral deep vein thrombosis in patients admitted to spe

130 Femoral deep vein thrombosis was diagnosed in 5 of 12 pa

131 endpoint of the study was the prevalence of femoral deep vein thrombosis within 48 h of SPCU admissi

132 evaluable scans, 92 (34%, 95% CI 28-40) had femoral deep vein thrombosis.

133 with advanced cancer admitted to SPCUs had a femoral deep vein thrombosis.

134 , increases of 30%, 25% and 8% (P < 0.05) in femoral Delta Q , popliteal and brachial artery FMD%, re

135 th SSI, including AIIS morphologic features, femoral distal cam, and associated soft-tissue injuries.

136 Fluid-induced changes in femoral dP/dtmax correlated with fluid-induced changes i

137 Femoral dP/dtmax increased by 46% after fluid infusion i

138 Femoral dP/dtmax increased with volume expansion in case

139 Therefore, femoral dP/dtmax is not a load-independent marker of lef

140 Femoral dP/dtmax strongly correlated with pulse and syst

141 Changes in femoral dP/dtmax, systolic, diastolic, and pulse femoral

142 Slipped capital femoral epiphysis (SCFE), a fracture through the physis

143 The femoral estimate of effective arterial elastance was mor

144 ssure, whereas effective arterial elastance (femoral estimate) and systemic vascular resistance did n

145 erwent arterial ultrasound (carotid [CP] and femoral [FP] plaques defined as intima-media thickness (

146 y outcomes were vertebral fracture, atypical femoral fracture (AFF), osteonecrosis of the jaw (ONJ),

147 h and without DDH (9 DDH-OA, 12 OA-only, one femoral fracture).

148 es increased risk for 2 rare harms: atypical femoral fractures (low SOE) and osteonecrosis of the jaw

149 lity fracture and 2.0, 2.5, 1.1, and 2.5 for femoral fractures, respectively (P < .001 for all except

150 status, we compared the chemical profiles of femoral gland exudate from adults caught on Wolf Volcano

151 and focused on two years in particular when femoral gland exudate was collected from adults during t

152 ality was 2.2% in the radial and 2.3% in the femoral group (P=0.76).

153 Avascular necrosis of femoral head (AVNFH) is a debilitating disease, which af

154 Osteonecrosis of the femoral head (ONFH) primarily results from ischemia/hypo

155 dy the heterogeneous properties of the human femoral head affected by a disease such as osteoarthriti

156 sex on hip shape at age 14 reflected flatter femoral head and smaller lesser trochanter in females co

157 glycan content, thickness, and volume of the femoral head articular cartilage.

158 from micro-computed tomography scans of the femoral head extracted from hip fracture patients betwee

159 As example, in the superior femoral head osteoarthritic specimens exhibited a more h

160 nted pectoral girdle, and low torsion of the femoral head relative to the condyles are hypothesized s

161 Femoral head trabecular bone tissue digests were sorted

162 iarthroplasty (prosthetic replacement of the femoral head) fixation via bony growth into a porous-coa

163 der), [1.80%, 0.48%](Body), [3.87%, 1.79%](L Femoral Head), [5.07%, 2.55%](R Femoral Head), and [1.26

164 7%, 1.79%](L Femoral Head), [5.07%, 2.55%](R Femoral Head), and [1.26%, 1.62%](Rectum) of the prescri

165 mes of interest spatially distributed in the femoral head, and bone morphometric properties were dete

166 imarily results from ischemia/hypoxia to the femoral head, and one of the cellular manifestations is

167 males still remained although differences in femoral head, femoral shaft and FNW were largely attenua

168 micro-architectural properties of the human femoral head, highlighting effects of OA in the superior

169 d artifacts due to simulated implants in the femoral head, sternum, and spine (P = 0.01, 0.01, and 0.

170 throughout the subchondral bone of the human femoral head.

171 affects the morphological properties of the femoral head.

172 to total hip replacement due to collapse of femoral head.

173 Whole femoral heads extracted from osteoarthritic (n = 5) and

174 R analysis performed on hMSCs (isolated from femoral heads of patients undergoing joint arthroplasty)

175 In vivo, femoral hematomas resolved completely between days 8 and

176 cholecystectomy, appendectomy, and inguinal/femoral hernia repair between November 1, 2013 and Novem

177 dice technique, if there is no evidence of a femoral hernia.

178 n of Ag(+) from intramedullary pins in a rat femoral implantation model, delivering a maximum potenti

179 re-expression immediately after their intra-femoral inoculation blocks tumor development and preserv

180 otection against bone destruction induced by femoral inoculation of Lewis lung cancer cells.

181 nting Gram-negative bacilli was high for the femoral insertion site.

182 layed by ACC in the early stages of OA.Tibio-femoral joints were obtained from BALB/c WT and BALB/c A

183 3 weeks, thrombus within 3 cm of the sapheno-femoral junction, indication for full-dose anticoagulati

184 ntral skeleton covering the skull to the mid-femoral level was performed before the first cycle of (2

185 on anatomical details such as the tibial and femoral morphology of the forelegs.

186 taneously breathing patients equipped with a femoral (n = 21) or radial (n = 29) catheter were entere

187 rochanter (0.026 +/- 0.006 g/cm2, P <0.001), femoral neck (0.022 +/- 0.006 g/cm2, P <0.001), total hi

188 sis at baseline at the lumbar spine (LS) and femoral neck (FN) was 17.6% and 7.2%, respectively.

189 populations, we built assessment models for femoral neck (FN)-fracture prediction and BMD value pred

190 detected signs of impingement on the distal femoral neck (IDFN) in 18 of the 20 patients with SSI (9

191 consortium for lumbar spine (n = 31,800) and femoral neck (n = 32,961) BMD, and from the arcOGEN cons

192 = .22) but declined at the hip (P = .04) and femoral neck (P = .02).

193 =0.22), but declined at the hip (p=0.04) and femoral neck (p=0.02).

194 sity (BMD) (g/cm(2)), lumbar spine L2-L4 and femoral neck (T-scores) (P = 0.0149, 0.0002 and 0.0139,

195 uRBP/uCr and DXA T scores (lumbar [P = .03], femoral neck [P < .001], and total hip [P = .002]).

196 sociated with fracture risk independently of femoral neck aBMD and the Fracture Risk Assessment Tool

197 Mean femoral neck aBMD had also increased to a greater extent

198 After further adjustment for femoral neck aBMD or FRAX score, the associations were r

199 load improved prediction of fracture beyond femoral neck aBMD or FRAX scores alone.

200 of -0.29 (-0.44 to -0.15, p < 0.001) at the femoral neck and of -0.25(-0.45 to -0.05, p = 0.015) at

201 The means +/- SDs of femoral neck BMD loss were -0.02 +/- 0.05 and 0.0 +/- 0.

202 dary endpoints comprised the dose effects on femoral neck BMD, falls, circulating calciotropic hormon

203 s total hip bone mineral density (BMD), with femoral neck BMD, lumbar spine BMD, and lumbar spine tra

204 : 1.5%, 5.1%) but no effect on total body or femoral neck BMD.

205 range of non-destructive metrics to measure femoral neck cortical bone stiffness at the millimetre l

206 ty, as measured by micro-CT, correlated with femoral neck cortical bone's elastic modulus and ultimat

207 eight, and cohort, and then additionally for femoral neck DXA aBMD or FRAX.

208 50 years of age or older and had a displaced femoral neck fracture to undergo either total hip arthro

209 CS for consolidation of impending pathologic femoral neck fracture with a mean follow-up of 533 days

210 isplaced femoral neck fracture, nondisplaced femoral neck fracture, intertrochanteric fracture, previ

211 ng boxes and classified as normal, displaced femoral neck fracture, nondisplaced femoral neck fractur

212 the hemiarthroplasty treatment of displaced femoral neck fractures in the absence of contraindicatio

213 pendently ambulating patients with displaced femoral neck fractures, the incidence of secondary proce

214 For displaced femoral neck fractures, there remains uncertainty regard

215 d fixation in hemiarthroplasty for displaced femoral neck fractures.

216 The cortex of the femoral neck is a key structural element of the human bo

217 s of cortical bone samples obtained from the femoral neck of hip replacement patients.

218 e postmenopausal for 5 years or more, with a femoral neck or total hip bone mineral density T-score b

219 es for preventive consolidation of impending femoral neck pathologic fractures.

220 ad incident fractures, of whom 633 (86%) had femoral neck T scores greater than -2.5.

221 -score of less than -4.0 at the total hip or femoral neck were not eligible unless they were unable o

222 At age 18, smaller lesser trochanter and femoral neck width (FNW) in females still remained altho

223 reater trochanter, femoral neck, base of the femoral neck, and level of the lesser trochanter.

224 Baseline total hip, femoral neck, and lumbar spine BMDs were 1.016 +/- 0.160

225 ents at the level of the greater trochanter, femoral neck, base of the femoral neck, and level of the

226 ssion, respectively, at the lumbar spine and femoral neck, stratified by male, premenopausal women, a

227 ndardized BMD (sBMD) at the lumbar spine and femoral neck, World Health Organization (WHO) BMD catego

228 on for impending pathologic fractures of the femoral neck.

229 core in the lumbosacral spine, total hip, or femoral neck.

230 S) for impending pathologic fractures of the femoral neck.

231 anced pelvic tumors involving the sciatic or femoral nerve have traditionally been considered inopera

232 iceps twitch force generation in response to femoral nerve magnetic stimulation, to assess leg streng

233 En bloc sciatic and femoral nerve resection can be performed during extended

234 plete sciatic, partial sciatic, and complete femoral nerve resection was performed in 26 (38%), 38 (5

235 s, 68 patients (9.5%) had en bloc sciatic or femoral nerve resection.

236 ery with en bloc resection of the sciatic or femoral nerves at a single center were included.

237 Measurements of femoral nutrient foramina show Morganucodon had blood fl

238 ing to whether they were performed through a femoral or a n-FP access, using a pre-specified propensi

239 Femoral osteophytes (FOs), acetabular osteophytes (AOs),

240 sociated with similar outcomes compared with femoral peripheral TAVR, except for a 2-fold lower rate

241 number score; 3DVUS to quantify carotid and femoral plaque volume; and coronary artery calcium score

242 fter 6 weeks from training cessation, in the femoral, popliteal (treated with stretching), and brachi

243 rgoing endovascular treatment of superficial femoral-popliteal artery disease in the Society for Vasc

244 are mortality after treatment of superficial femoral-popliteal artery disease with paclitaxel and non

245 st-effectiveness ratio of $137 526/QALY; for femoral-popliteal DVT, standard therapy was an economica

246 was similar if not lower after treatment of femoral-popliteal occlusive disease with paclitaxel vers

247 Chemical signature of femoral pore secretions is important for intra- and inte

248 eliably estimated at bedside (0.9 x systolic femoral pressure/stroke volume).

249 2009 and 2012-2013) by measuring the carotid-femoral pulse wave velocity (cf-PWV).

250 e evaluated the relationship between carotid femoral pulse wave velocity (cfPWV) and T-cell activatio

251 -17 years and arterial stiffness (carotid to femoral pulse wave velocity [PWV]) measured at age 17 ye

252 adjusted between-group difference in carotid-femoral pulse wave velocity at 12 months.

253 nge in the weight-loss group, but carotid-to-femoral pulse wave velocity tended to decrease by 0.5 m/

254 ar mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arterio

255 We analyzed the primary outcome, carotid-femoral pulse wave velocity, using a linear mixed effect

256 Carotid femoral pulse-wave velocity (cfPWV) measured arterial st

257 garding the landmark levels for the proximal femoral reference axis and included measurements at the

258 risk, 2.25 [95% CI, 1.84-2.75]; I = 0%) and femoral (relative risk, 2.92 [95% CI, 2.11-4.04]; I = 24

259 familial hypercholesterolemic swine model of femoral restenosis.

260 ce on catheter-related bloodstream infection femoral risk, compared with the other sites, is inconclu

261 The PCL resection yielded a decrease of femoral rollback by 4.5 mm and a reduction of tibiofemor

262 ntact force by about 170 N and a decrease of femoral rollback up to 1.7 mm.

263 arly increased the contact force and lateral femoral rollback.

264 In addition, the adduction and femoral rotation increased internally at the heel strike

265 rtment and controlled by (2) carotid and (3) femoral samples obtained under physiological flow condit

266 Femoral sections were assessed for the abundance of Tart

267 used in spaceflight (Flight + Sham); and (4) Femoral segmental bone defect surgery mice housed in spa

268 ice housed on the earth (Ground + Sham); (2) Femoral segmental bone defect surgery mice housed on the

269 mained although differences in femoral head, femoral shaft and FNW were largely attenuated following

270 rgoing intramedullary nail fixation of their femoral shaft fractures at a university-based level-1 tr

271 bacilli were more frequently observed at the femoral site (20% vs nonfemoral site 12%; p = 0.01).

272 bacilli were more frequently detected at the femoral site (31% vs 4% for nonfemoral site; p < 0.01).

273 fter adjustment for confounding factors, the femoral site was still associated with an increased risk

274 ng 21,611 patients, 19,995 (92.5%) underwent femoral TAVR and 1,616 (7.5%) underwent n-FP TAVR (trans

275 ry in patients who are deemed ineligible for femoral TAVR and may be a safe alternative when femoral

276 pared nonfemoral peripheral (n-FP) TAVR with femoral TAVR.

277 VUS) of abdominal aorta, carotid, iliac, and femoral territories to determine a plaque number score;

278 Bilateral carotid and femoral territories were explored by 3DVUS to determine

279 roducibility, and reliability and to compare femoral torsion angles between the four different measur

280 Background Assessment of femoral torsion at preoperative hip imaging is commonly

281 e To compare MRI- and CT-based assessment of femoral torsion by using four commonly used measurement

282 Conclusion MRI- and CT-based femoral torsion measurements showed high agreement and c

283 urate as CT and how different methods affect femoral torsion measurements.

284 o those in human milk to this diet increased femoral trabecular bone volume and cortical thickness, r

285 ge sets (all P >= .07) except for two items (femoral trochlear cartilage [3.0% vs 0.3%, P = .006] and

286 cardiac perforation, device dislocation, and femoral vascular access site complications.

287 rosclerosis as assessed by bilateral carotid/femoral vascular ultrasound.

288 cs on blood from artery, coronary sinus, and femoral vein in 110 patients with or without heart failu

289 empted tricuspid valve repair procedure upon femoral vein puncture.

290 utive adults with cancer underwent bilateral femoral vein ultrasonography on admission and weekly unt

291 ioMEMS) is approved for implantation via the femoral vein.

292 ization of the right femoral artery and left femoral vein.

293 Patients with postthrombotic femoral veins and those who received multiple stents wer

294 ariable Cox regression model, postthrombotic femoral veins at baseline (hazard ratio, 2.64 [95% CI, 1

295 ein thrombosis involving the iliac or common femoral veins were randomized to PCDT with anticoagulati

296 A femoral venous approach was used to gain right and left

297 Radial artery and femoral venous blood gases were measured.

298 output, leg blood flow and radial artery and femoral venous blood gases were measured.

299 olonization according to the insertion type (femoral vs nonfemoral) included in the four studies.

300 ed twenty-two RA cases (3069 radial and 5553 femoral) were included in the analysis.